• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Mergers and Acquisitions in the IVD Market

$995.00 – $1,990.00

Clear
SKU: KLI15643712 Categories: Diagnostics Market Research, Point-of-Care Diagnostics Pages: 85
  • Description
  • Table of Contents
  • Latest reports

Description

Mergers and Acquisitions in the IVD Market

Mergers and Acquisitions in the IVD Market records over 220 acquisitions in the in vitro diagnostics (IVD) industry in total, featuring approximately 152 purchase arrangements in 2015-2016 and 69 acquisitions in IVD and related segments so far from 2017 to March 2018.

Among the leading diagnostics companies looking to increase market share and produce revenue growth via acquisition are Abbott/Alere, Beckman Coulter / Danaher, and Roche. Abbott’s acquisition of Alere and related divestures and Danaher’s acquisition of Cepheid are among the specific deals discussed in the report.

The report also details acquisitions driven by the development of cutting-edge technologies such as gene editing, liquid biopsy, microbiome research, and next-generation sequencing.

Gene Editing

Liquid Biopsy

Microbiome

Next-Generation Sequencing

Automation, and the Introduction of New, Large, Automated Platforms

Rapid Point-of-Care Testing with Single Pathogen Infectious Disease Tests

Connectivity

Looking to the East

Table of Contents

1: EXECUTIVE SUMMARY

THE MARKET LANDSCAPE

Roche

Abbott/Alere

Siemens

Beckman Coulter, Inc. / Danaher

The Changing Landscape

MARKET TRENDS HELPING TO DRIVE MERGERS AND ACQUISITIONS

Gene Editing

Liquid Biopsy

Next-Generation Sequencing

Automation, and the Introduction of New, Large, Automated Platforms

Rapid Point-of-Care Testing with Single Pathogen Infectious Disease Tests

Connectivity

Looking to the East

Microbiome

METHODOLOGY

2: IVD MERGERS AND ACQUISITIONS

OVERVIEW: THE IVD INDUSTRY – A CHANGING MARKET

M&A IN SELECTED MARKETS

Lab-Developed Test (LDT) Services Market

The PCR/NAAT Market

Table 2-1: Selected Acquisitions of Diagnostic Companies, from 2017 to mid-March 2018

SELECTED 2017 / 2018 ACQUISITIONS OF NOTE

Abbott: Acquisitions, Divestures and the Alere Deal

Siemens’ Divestiture of a Portion of Its Healthcare Business, Siemens Healthineers

Roche Active in M&A, Part 1

Celgene Active in Early 2018

Agilent Makes Cell Analysis Buy

Charles River Labs Acquires KWS BioTest

Early 2018 M&A Activity in Biotech — Sanofi Buys Bioverativ, Ablynx

Chembio Diagnostics Acquires Malaysian Firm RVR Diagnostics

Konica Minolta Acquires Ambry Genetics

Quidel Amends Alere Deal

Thermo Completes Patheon Acquisition

Agilent Acquires the Molecular and Sample Barcoding Patent Portfolios of Population Genetics

Enterome and Nestle Health Science Form Microbiome Diagnostics Partners

PerkinElmer Expansion via Tulip and Euroimmun Acquisitions

Sysmex Acquires Oxford Gene Technology (OGT)

LabCorp Completes PAML Acquisition

Cathay Fortune International Acquires Molecular Diagnostics Firm Epigenomics

Bio-Rad Acquires ddPCR Developer RainDance

QIAGEN M&A Activity

Agilent Completes the Acquisition of Multiplicom

Grifols Acquires NAT Donor Screening Unit from Hologic

Johnson & Johnson Diabetes Business Attracts Chinese Interest

THE 2015-2016 MARKET

Table 2-2: Selected Acquisitions of Diagnostic Companies, 2015-2016

SELECTED 2015 / 2016 ACQUISITIONS OF NOTE

Roche Active in M&A, Part 2

Danaher’s Acquires Molecular Diagnostics Leader Cepheid for Nearly $4 Billion

Abbott Acquires St. Jude Medical, Adds Patient Monitoring and Neurostimulation Strength

Thermo Fisher Scientific Completes Major Deals in 2016

Beckman Coulter Acquires Siemens Healthcare Diagnostics’ Clinical Microbiology Business

Becton Dickinson (BD) Prepares Its Entrance into Sequencing with Cellular Research Acquisition

Founding CTC Technology Finds Another Home

Curetis Acquires Real-Time qPCR-based Gyronimo Platform from Carpegen GmbH and Systec GmbH . 73

Bruker Acquires Nucleic Acid Testing Assays and Syndromic Panel Technology

LabCorp Completes Its Acquisition of Sequenom

Curetis Acquires Asset from Siemens Technology Accelerator

Debiopharm Group Acquires GenePOC

Luminex Seeks to Leverage Nanosphere’s Verigene Platform

Siemens Expands Its Diagnostics Portfolio

Quest and DiaSorin to Focus on Key Markets Following Acquisition Deal

Immucor Acquires Sirona Genomics

Illumina Establishes GRAIL Bio

Charles River Acquires Agilux, WIL Research, and Oncotest

IBM Healthcare/Watson Continues Expansion

BD Acquires CareFusion

 

    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025

Related products

  • Placeholder image

    U.S. Market for Molecular Diagnostics, 2nd Edition

    $3,500.00 – $7,000.00
  • Placeholder image

    Molecular Diagnostics for Infectious Disease Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Biophotonics – A Strategic Assessment of Photonics Technologies for Biomedical Applications

    $2,995.00 – $5,990.00
  • Placeholder image

    In Vitro Diagnostic Tests and Systems: The World Outside the United States

    $596.00 – $1,192.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Point of Care (POC) Infectious Disease Diagnostic Testing MarketPoint of Care Diagnostics Market in Retail Clinics (Cholesterol, Diabetes, Influenza,...
Scroll to top